a month ago
LGND
AnalystsRobert WassermanRobert Wasserman's Stock Forecasts
AnalystsRobert Wasserman
Analyst Ranking
Top 20%
#1009 out of 5153 analysts
Average Return
+5.16%
Win Rate
47%54 out of 114
Risk vs Reward
Poor
Good
Robert Wasserman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Mindwalk Holdings CorpHYFT | +397.22% | $0.36 | $1.79 | 2025-03-31 - 2025-12-15 | Buy |
Mindwalk Holdings CorpHYFT | +192.65% | $0.68 | $1.99 | 2024-08-13 - 2025-08-13 | Buy |
Molekule Group IncMKULQ | +174.00% | $5.00 | $13.70 | 2022-01-31 - 2022-06-14 | Buy |
Nephros IncNEPH | +164.02% | $1.64 | $4.33 | 2024-11-11 - 2025-11-11 | Buy |
Ligand Pharmaceuticals IncLGND | +119.54% | $92.48 | $203.03 | 2020-02-05 - 2021-02-05 | Strong Buy |
Robert Wasserman Analyst Color
Get additional color on Robert Wasserman's coverage of popular stocks
a month ago
PRLB
3 months ago
LGND
a year ago
ITGR
a year ago
LGND
Robert Wasserman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ligand Pharmaceuticals IncLGND | 12 | Strong Buy | $220.00 | +14.06% | Maintains | a month ago |
Proto Labs IncPRLB | 7 | Strong Buy | $55.00 | +4.92% | Maintains | a month ago |
Halozyme Therapeutics IncHALO | 10 | Strong Buy | $90.00 | +41.84% | Maintains | 3 months ago |
Intensity Therapeutics IncINTS | 7 | Buy | $1.50 | +253.77% | Maintains | 4 months ago |
Bio Techne CorpTECH | 7 | Strong Buy | $75.00 | +27.79% | Reiterates | 6 months ago |
Kamada LtdKMDA | 2 | Strong Buy | $15.00 | +106.90% | Reiterates | 7 months ago |
Omniab IncOABI | 9 | Strong Buy | $6.00 | +195.57% | Reiterates | 7 months ago |
Integer Holdings CorpITGR | 11 | Strong Buy | $140.00 | +91.54% | Maintains | 8 months ago |
Xoma Royalty CorpXOMA | 1 | Strong Buy | $35.00 | +37.31% | Initiates Coverage On | 8 months ago |
Mindwalk Holdings CorpHYFT | 6 | Buy | $3.00 | +67.60% | Reiterates | 8 months ago |
Biolife Solutions IncBLFS | 4 | Strong Buy | $30.00 | +21.70% | Reiterates | a year ago |
Anebulo Pharmaceuticals IncANEB | 6 | Buy | $8.00 | N/A | Reiterates | a year ago |
Nephros IncNEPH | 3 | Buy | $5.00 | N/A | Reiterates | a year ago |
Emergent Biosolutions IncEBS | 16 | Strong Buy | $12.00 | N/A | Maintains | a year ago |
Codexis IncCDXS | 4 | Strong Buy | $9.00 | N/A | Reiterates | 2 years ago |
Alterity Therapeutics LtdATHE | 1 | Buy | $4.00 | N/A | Reiterates | 2 years ago |
Processa Pharmaceuticals IncPCSA | 1 | Buy | $4.00 | N/A | Reiterates | 2 years ago |
Abcellera Biologics IncABCL | 2 | Strong Buy | $12.00 | N/A | Maintains | 2 years ago |
Molekule Group IncMKULQ | 4 | Buy | $7.00 | N/A | Reiterates | 3 years ago |
Fortress Biotech IncFBIO | 1 | Buy | $75.00 | N/A | Reiterates | 3 years ago |
Repligen CorpRGEN | 1 | Strong Buy | $230.00 | N/A | Initiates Coverage On | 3 years ago |
Danaher CorpDHR | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Thermo Fisher Scientific IncTMO | 1 | Strong Buy | $580.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.